A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy

Clinical trial NCT07342517 · WITHDRAWN

Trial details

NCT number: NCT07342517
Sponsor: Relmada Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Bladder (Urothelial, Transitional Cell) Cancer Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Urothelial Carcinoma Bladder Urothelial Carcinoma Recurrent Urologic Cancer

Start date: 2026-06-30
Primary completion: 2027-06-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.